Vitrolife AB (publ) (LON:0YAY)
London · Delayed Price · Currency is GBP · Price in SEK 135.20
+0.20 (0.15%)
At close: Sep 12, 2025
Vitrolife AB Market Cap
Vitrolife AB has a market cap or net worth of 1.46 billion as of September 16, 2025. Its market cap has decreased by -35.48% in one year.
Market Cap
1.46B
Enterprise Value
1.55B
Revenue
271.79M
Ranking
n/a
PE Ratio
41.85
Stock Price
135.20
Market Cap Chart
Since June 27, 2001, Vitrolife AB's market cap has increased from 33.54M to 1.46B, an increase of 4,258.40%. That is a compound annual growth rate of 16.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 1.44B | -31.44% |
| Dec 30, 2024 | 2.11B | 2.64% |
| Dec 29, 2023 | 2.05B | 2.23% |
| Dec 30, 2022 | 2.01B | -67.68% |
| Dec 30, 2021 | 6.21B | 195.37% |
| Dec 30, 2020 | 2.10B | 20.08% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.94B |
| GSK plc | 58.89B |
| Haleon | 31.92B |
| Smith & Nephew | 11.94B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.12B |
| Genus | 1.65B |